Funding round brings in $6.4M for developer of Alzheimer's drug

05/7/2013 | MedCityNews.com

NeuroPhage Pharmaceuticals secured $6.4 million in a funding round led by Mérieux Développement. The company will use the proceeds to advance development of its potential Alzheimer's drug NPT002, which is in preclinical development. The firm plans to submit an investigational new drug application and begin clinical trials next year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care